News
Print PDF

Practice Areas

Imports and Exports of Synthetic Cannabinoids Restricted

Monday, April 10, 2017
Sandler, Travis & Rosenberg Trade Report

The Drug Enforcement Administration has issued an order that temporarily schedules the following six synthetic cannabinoids, along with their optical, positional, and geometric isomers, salts, and salts of isomers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.

- methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate

- methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate

- N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide

- N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide

- methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate

- methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate

As a result, these substances are subject to the regulatory controls and administrative, civil, and criminal sanctions applicable to the manufacture, distribution, reverse distribution, importation, exportation, research, conduct of instructional activities and chemical analysis, and possession of schedule I controlled substances. This order is effective April 10 and will be in effect for two years, with a possible extension of one year, pending completion of the permanent scheduling process.

According to the DEA, available data and information indicate that these substances have a high potential for abuse, no currently accepted medical use in treatment in the U.S., and a lack of accepted safety for use under medical supervision.

To get news like this in your inbox daily, subscribe to the Sandler, Travis & Rosenberg Trade Report.

Customs & International Headlines